AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 15 filers reported holding AMBRX BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,252,167 | -44.3% | 1,761,058 | -20.3% | 0.00% | -33.3% |
| Q2 2023 | $36,386,772 | -7.7% | 2,210,618 | -50.0% | 0.00% | +50.0% |
| Q1 2023 | $39,437,426 | +544.4% | 4,421,236 | +64.0% | 0.00% | +100.0% |
| Q4 2022 | $6,120,066 | +57.9% | 2,696,064 | -24.9% | 0.00% | – |
| Q3 2022 | $3,876,000 | -62.1% | 3,588,467 | -7.0% | 0.00% | -100.0% |
| Q2 2022 | $10,223,000 | -35.1% | 3,857,679 | +0.8% | 0.00% | 0.0% |
| Q1 2022 | $15,760,000 | -54.7% | 3,825,359 | -0.8% | 0.00% | -66.7% |
| Q4 2021 | $34,811,000 | -30.8% | 3,855,025 | -0.0% | 0.00% | -25.0% |
| Q3 2021 | $50,300,000 | -26.8% | 3,856,225 | +2.4% | 0.00% | -20.0% |
| Q2 2021 | $68,727,000 | – | 3,766,940 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 11,304,573 | $100,836,791 | 27.58% |
| COMMODORE CAPITAL LP | 4,803,447 | $42,846,747 | 6.52% |
| VR Adviser, LLC | 3,298,577 | $29,423,307 | 5.74% |
| Cormorant Asset Management, LP | 8,500,000 | $75,820 | 4.99% |
| Ghost Tree Capital, LLC | 250,000 | $2,230,000 | 0.66% |
| TOMS Capital Investment Management LP | 1,000,000 | $8,920,000 | 0.55% |
| Artal Group S.A. | 702,291 | $6,264 | 0.37% |
| Fosun International Ltd | 249,190 | $2,222,775 | 0.21% |
| D. E. Shaw & Co., Inc. | 3,933,552 | $35,087,284 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 361,000 | $3,220,120 | 0.02% |